Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
7,096,625
-
Total 13F shares
-
5,236,560
-
Share change
-
+19,804
-
Total reported value
-
$136,991,051
-
Price per share
-
$26.11
-
Number of holders
-
47
-
Value change
-
-$2,438,948
-
Number of buys
-
29
-
Number of sells
-
17
Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG) as of Q2 2025
As of 30 Jun 2025,
BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,236,560 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Cormorant Asset Management, LP, Sio Capital Management, LLC, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., MORGAN STANLEY, and Point72 Asset Management, L.P..
This page lists
47
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.